Published: January 2021
This Advisory, based on TIP 49, Incorporating Alcohol Pharmacotherapies Into Medical Practice, focuses on medication and related treatment decisions made after screening and assessment for AUD, and medically supervised withdrawal, if necessary. Alcohol consumption should not stop abruptly in those patients who have consumed alcohol regularly over a prolonged period of time. This Advisory is meant as an overview of AUD medications to facilitate abstinence.
Published: December 2020
The book is composed of SAMHSA’s “National Guidelines for Behavioral Health Crisis Care: Best Practice Toolkit” and related papers on crisis services. The toolkit reflects relevant clinical and health services research, review of top national program practices and replicable approaches that support best practice implementation. The related papers address key issues relevant to crisis services, homelessness, technology advances, substance use, legal issues impacting crisis services, financing crisis care, diverse populations, children and adolescents, rural and frontier areas, and the role of law enforcement.
Published: October 2020
This fact sheet provides parents, caregivers, and teachers with strategies for helping children manage their stress during an infectious disease outbreak. It describes potential reactions among youth and the support adults can provide to help them.
Esta hoja informativa ofrece a los padres, cuidadores y maestros estrategias para ayudar a los niños a controlar el estrés durante un brote de enfermedades infecciosas. Describe las posibles reacciones de los jóvenes y el apoyo que los adultos pueden brindar para ayudarlos.
Published: July 2020
The wallet card provides stress reduction tips and techniques as well as lists sources for additional assistance.
Published: May 2020
The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
Published: December 2019
This guide supports health care providers, systems, and communities seeking to prevent marijuana use by pregnant women. It describes relevant research findings, examines emerging and best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.
Published: October 2019
The guide provides public officials as well as others involved in disaster and emergency communications with information about effective communication, working with the media, using social media, and addressing errors and controlling rumors.
Published: June 2019
This action brief provides rural communities recommended strategies for adapting promising or proven interventions to better support crisis response and pre-arrest diversion in their communities. It is the first of three briefs developed from the SAMHSA Pre-Arrest Diversion Expert Panel.
The National report presents indicators as measured through the 2017 National Survey on Drug Use and Health and the National Survey of Substance Abuse Treatment Services. State reports provide a snapshot of substance use and mental health in the United States.
Millions of Americans have a substance use disorder. Find a treatment facility near you.
Free and confidential support for people in distress, 24/7.
Find treatment facilities confidentially and anonymously, 24/7.
Treatment referral and information, 24/7.
Visit the SAMHSA Facebook page
Visit SAMHSA on Twitter
Visit the SAMHSA YouTube channel
Visit SAMHSA on LinkedIn
To sign up for updates or to access your subscriber preferences, please enter your contact information.
Have a question about government service? Contact USA.gov.